Literature DB >> 15207162

[The Spanish version of the German health-related quality of life questionnaire for children and adolescents: the Kindl].

L Rajmil1, V Serra-Sutton, J A Fernandez-Lopez, S Berra, M Aymerich, A Cieza, M Ferrer, M Bullinger, U Ravens-Sieberer.   

Abstract

OBJECTIVES: To obtain a Spanish version of the Kindl semantically and culturally equivalent to the original German version and to test its psychometric properties.
MATERIAL AND METHODS: The methodology used in the adaptation process was based on the forward-backward translation method. To assess the psychometric properties of the Spanish Kindl, the pilot test of the project "Screening for and promotion of HRQL in children and adolescents: a European Public Health perspective (Kidscreen)" it was include in. A classroom was selected for each educational level (8-16 years old) from three schools in Gerona and Barcelona. The Spanish Kindl was administered twice, one week apart. Internal consistency was assessed by computing Cronbach alpha and test-retest stability was assessed using intraclass correlation coefficients (ICC). Analysis of variance was performed according to age, sex, type of school, and self-perceived health status.
RESULTS: Half of the items (12/24) required minor changes during the adaptation process. The response rate was 91 % (n = 447). Internal consistency was acceptable for most domains (alpha range = 0.40-0.88), as was test-retest stability (ICC range = 0.52-0.80). Girls and older teenagers scored worse in most domains (p < 0.01). No differences were found by type of school.
CONCLUSIONS: The Spanish version of the Kindl showed adequate reliability and validity coefficients and represents a new HRQL instrument that can be applied in pediatric clinical practice and public health.

Entities:  

Mesh:

Year:  2004        PMID: 15207162     DOI: 10.1016/s1695-4033(04)78320-4

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  6 in total

1.  Testing the structural and cross-cultural validity of the KIDSCREEN-27 quality of life questionnaire.

Authors:  Stephane Robitail; Ulrike Ravens-Sieberer; Marie-Claude Simeoni; Luis Rajmil; Jeanet Bruil; Mick Power; Wolfgang Duer; Bernhard Cloetta; Ladislav Czemy; Joanna Mazur; Agnes Czimbalmos; Yannis Tountas; Curt Hagquist; Jean Kilroe; Pascal Auquier
Journal:  Qual Life Res       Date:  2007-08-01       Impact factor: 4.147

Review 2.  Quality of life in patients with food allergy.

Authors:  Darío Antolín-Amérigo; Luis Manso; Marco Caminati; Belén de la Hoz Caballer; Inmaculada Cerecedo; Alfonso Muriel; Mercedes Rodríguez-Rodríguez; José Barbarroja-Escudero; María José Sánchez-González; Beatriz Huertas-Barbudo; Melchor Alvarez-Mon
Journal:  Clin Mol Allergy       Date:  2016-02-17

3.  Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC.

Authors:  Anja Weiß; Kirsten Minden; Joachim Listing; Ivan Foeldvari; Joachim Sieper; Martin Rudwaleit
Journal:  RMD Open       Date:  2017-03-21

4.  Serbian KINDL questionnaire for quality of life assessments in healthy children and adolescents: reproducibility and construct validity.

Authors:  Dejan Stevanovic
Journal:  Health Qual Life Outcomes       Date:  2009-08-28       Impact factor: 3.186

5.  Population norms and cut-off-points for suboptimal health related quality of life in two generic measures for adolescents: the Spanish VSP-A and KINDL-R.

Authors:  Vicky Serra-Sutton; Montse Ferrer; Luis Rajmil; Cristian Tebé; Marie-Claude Simeoni; Ulrike Ravens-Sieberer
Journal:  Health Qual Life Outcomes       Date:  2009-04-21       Impact factor: 3.186

6.  Physical activity intervention (Movi-Kids) on improving academic achievement and adiposity in preschoolers with or without attention deficit hyperactivity disorder: study protocol for a randomized controlled trial.

Authors:  Mairena Sánchez-López; María Jesús Pardo-Guijarro; David Gutiérrez-Díaz Del Campo; Pedro Silva; Maria Martínez-Andrés; Roberto Gulías-González; Ana Díez-Fernández; Pablo Franquelo-Morales; Vicente Martínez-Vizcaíno
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.